VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
NCT02718443
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
VXM01
Sponsor
Vaximm GmbH